株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

双極性障害(躁鬱病):世界の治験レビュー

Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2017

発行 GlobalData 商品コード 306652
出版日 ページ情報 英文 600 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.47円で換算しております。
Back to Top
双極性障害(躁鬱病):世界の治験レビュー Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2017
出版日: 2017年04月30日 ページ情報: 英文 600 Pages
概要

当レポートでは、双極性障害(躁鬱病)に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7諸国およびE7(新興7カ国)における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

目次

イントロダクション

  • 双極性障害(躁鬱病)
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域上位5ヶ国における治験件数
    • 欧州上位5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカの上位5ヵ国における治験件数
    • ラテンアメリカの上位5ヶ国における治験件数

G7諸国における治験件数:中枢神経系治験に対する双極性障害(躁鬱病)治験件数比率

G7諸国における治験件数:フェーズ(相)別

G7諸国における治験件数:進捗状況別

E7(新興7カ国)における治験件数:中枢神経系に対する双極性障害(躁鬱病)の治験件数比率

E7(新興7カ国)における治験件数:フェーズ(相)別

E7(新興7カ国)における治験件数:進捗状況別

治験件数:フェーズ(相)別

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

最新の治験ニュース

治験のプロファイル

  • 代表的企業の治験の概要
    • AstraZeneca PLC
    • Clinical Trial Overview of AstraZeneca PLC
    • Eli Lilly and Company
    • Clinical Trial Overview of Eli Lilly and Company
    • Pfizer Inc.
    • Clinical Trial Overview of Pfizer Inc.
    • Johnson & Johnson
    • Clinical Trial Overview of Johnson & Johnson
    • Otsuka Holdings Co., Ltd.
    • Clinical Trial Overview of Otsuka Holdings Co., Ltd.
    • GlaxoSmithKline plc
    • Clinical Trial Overview of GlaxoSmithKline plc
    • Abbott Laboratories
    • Clinical Trial Overview of Abbott Laboratories
    • Merck & Co., Inc.
    • Clinical Trial Overview of Merck & Co., Inc.
    • Bristol-Myers Squibb Company
    • Clinical Trial Overview of Bristol-Myers Squibb Company
    • Novartis AG
    • Clinical Trial Overview of Novartis AG
  • 代表的な研究機関病院の治験の概要
    • National Institute of Mental Health
    • Clinical Trial Overview of National Institute of Mental Health
    • Massachusetts General Hospital
    • Clinical Trial Overview of Massachusetts General Hospital
    • University of Pittsburgh
    • Clinical Trial Overview of University of Pittsburgh
    • U.S. Department of Veterans Affairs
    • Clinical Trial Overview of U.S. Department of Veterans Affairs
    • Mclean Hospital
    • Clinical Trial Overview of Mclean Hospital
    • University of Texas Southwestern Medical Center at Dallas
    • Clinical Trial Overview of University of Texas Southwestern
  • Medical Center at Dallas
    • University of Cincinnati
    • Clinical Trial Overview of University of Cincinnati
    • University of British Columbia
    • Clinical Trial Overview of University of British Columbia
    • University Hospitals of Cleveland
    • Clinical Trial Overview of University Hospitals of Cleveland
    • Lindner Center of HOPE
    • Clinical Trial Overview of Lindner Center of HOPE

5つの代表的な治験のプロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2017" provides an overview of Bipolar Disorder (Manic Depression) clinical trials scenario. This report provides top line data relating to the clinical trials on Bipolar Disorder (Manic Depression). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Five Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials 20
  • Clinical Trials by Phase in E7 Countries 22
  • Clinical Trials in E7 Countries by Trial Status 23
  • Clinical Trials by Phase 24
  • In Progress Trials by Phase 25
  • Clinical Trials by Trial Status 26
  • Clinical Trials by End Point Status 28
  • Subjects Recruited Over a Period of Time 29
  • Clinical Trials by Sponsor Type 30
  • Prominent Sponsors 31
  • Top Companies Participating in Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials 33
  • Prominent Drugs 35
  • Latest Clinical Trials News on Bipolar Disorder (Manic Depression) 36
  • May 08, 2017: Intra-Cellular Therapies Presents Data Supporting the Potential for Potent and Rapid Antidepressant Activity with Lumateperone 36
  • Apr 03, 2017: Aequus Announces Positive Results from Second Proof of Concept Study for Long-Acting Aripiprazole Transdermal Patch 36
  • Mar 31, 2017: Sunovion to Present Data on LATUDA (lurasidone HCI) at the 25th European Congress of Psychiatry 36
  • Feb 27, 2017: Sunovion Announces Positive Topline Results from Study Evaluating Latuda (lurasidone HCl) in Children and Adolescents with Bipolar Depression 37
  • Feb 14, 2017: Aequus Successfully Completes Dosing in Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch 38
  • Clinical Trial Profile Snapshots 39

Appendix 596

  • Abbreviations 596
  • Definitions 596
  • Research Methodology 597
  • Secondary Research 597
  • About GlobalData 598
  • Contact Us 598
  • Source 599

List of Tables

List of Tables

  • Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
  • Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 16
  • Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 21
  • Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
  • Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
  • Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Phase, 2017* 24
  • Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 25
  • Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 27
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 28
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 29
  • Bipolar Disorder (Manic Depression) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 30
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 32
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 34
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 35

List of Figures

List of Figures

  • Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
  • Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 16
  • Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 20
  • Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
  • Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
  • Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 24
  • Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 25
  • Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 28
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 29
  • Bipolar Disorder (Manic Depression) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 30
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 33
  • Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 35
  • GlobalData Methodology 597
Back to Top